EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

Atrial Fibrosis and Inflammation in Postoperative Atrial Fibrillation

Sandrine Parent, Jennifer St Amant, Sophie Van Remortel, Saad Kahn, Ramana Vaka, David Courtman, Duncan John Stewart, Darryl Raymond Davis

JACC: Clinical Electrophysiology · 2024-06 · 10 (6) · 1037-1049

DOI: 10.1016/j.jacep.2024.02.019 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift JACC: Clinical Electrophysiology, 2024-06. Verfasst von Sandrine Parent und 7 weiteren Autor:innen. Beteiligte Einrichtung: University of Ottawa Heart Institute, Division of Cardiology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Ce…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Colchicine, Amiodarone, Rats, Sprague-Dawley. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Extracellular vesicles (EVs) isolated from human heart-derived cells have shown promise in suppressing inflammation and fibroblast proliferation. However, their precise benefits in atrial fibrillation (AF) prevention and the role of their antifibrotic/anti-inflammatory properties remain unclear. OBJECTIVES: The purpose of this study was to conduct a head-to-head comparison of antiarrhythmic strategies to prevent postoperative AF using a rat model of sterile pericarditis. Specifically, we aimed to assess the efficacy of amiodarone (a classic antiarrhythmic drug), colchicine (an anti-inflammatory agent), and EVs derived from human heart-derived cells, which possess anti-inflammatory and antifibrotic properties, on AF induction, inflammation, and fibrosis progression. METHODS: Heart-derived cells were cultured from human atrial appendages under serum-free xenogen-free conditions. Middle-aged Sprague Dawley rats were randomized into different groups, including sham operation, sterile pericarditis with amiodarone treatment, sterile pericarditis with colchicine treatment (2 dose levels), and sterile pericarditis with intra-atrial injection of EVs or vehicle. Invasive electrophysiological testing was performed 3 days after surgery before sacrifice. RESULTS: Sterile pericarditis increased the likelihood of inducing AF. Colchicine and EVs exhibited anti-inflammatory effects, but only EV treatment significantly reduced AF probability, whereas colchicine showed a positive trend without statistical significance. EVs and high-dose colchicine reduced atrial fibrosis by 46% ± 2% and 26% ± 2%, respectively. Amiodarone prevented AF induction but had no effect on inflammation or fibrosis. CONCLUSIONS: In this study, both amiodarone and EVs prevented AF, whereas treatment with colchicine was ineffective. The additional anti-inflammatory and antifibrotic effects of EVs suggest their potential as a comprehensive therapeutic approach for AF prevention, surpassing the effects of amiodarone or colchicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationColchicineAmiodaroneRats, Sprague-DawleyFibrosisAnti-Arrhythmia AgentsAnimalsRatsHumansMaleHeart AtriaInflammationPostoperative ComplicationsAnti-Inflammatory AgentsPericarditisExtracellular VesiclesDisease Models, AnimalCells, Cultured

Stichwörter der Autor:innen

atrial fibrillationexosomesextracellular vesiclespostoperative

Substanzen

ColchicineAmiodaroneAnti-Arrhythmia AgentsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • University of Ottawa Heart Institute, Division of Cardiology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario,…
  • Ottawa Hospital Research Institute, Division of Regenerative Medicine, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
  • Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada; Ottawa Hospital Research Institute, Division of Regenerative Medicine, Department of Medicine, University of Ottawa, Ottawa,…

Förderung

  • Canadian Institutes of Health Research
  • Natural Sciences and Engineering Research Council of Canada

Zitieren

APA

Parent, S., Amant, J. S., Remortel, S. V., Kahn, S., Vaka, R., Courtman, D., Stewart, D. J., & Davis, D. R. (2024). Atrial Fibrosis and Inflammation in Postoperative Atrial Fibrillation. JACC: Clinical Electrophysiology, 10(6), 1037-1049. https://doi.org/10.1016/j.jacep.2024.02.019

Vancouver

Parent S, Amant JS, Remortel SV, Kahn S, Vaka R, Courtman D, et al. Atrial Fibrosis and Inflammation in Postoperative Atrial Fibrillation. JACC: Clinical Electrophysiology. 2024;10(6):1037-1049. doi:10.1016/j.jacep.2024.02.019

BibTeX
@article{Parent2024,
  author = {Parent, Sandrine and Amant, Jennifer St and Remortel, Sophie Van and Kahn, Saad and Vaka, Ramana and Courtman, David and Stewart, Duncan John and Davis, Darryl Raymond},
  title = {Atrial Fibrosis and Inflammation in Postoperative Atrial Fibrillation},
  journal = {JACC: Clinical Electrophysiology},
  year = {2024},
  volume = {10},
  number = {6},
  pages = {1037--1049},
  doi = {10.1016/j.jacep.2024.02.019}
}
Kostenlos starten →